REF 822 IMUBIND(R) Plasma PAI-1 ELISA The
American Diagnostica, Inc. began a recall of REF 822 IMUBIND(R) Plasma PAI-1 ELISA The intended use: Product is an enzyme-linked immunosorbent assay for the quantative measurement of human Plasminogen... on . The reason FDA records is "Unacceptable microwell to microwell variation in the section of the plate that is typically used for the calibrators". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.
Recall record
- Recall number
- Z-1426-2010
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Sekisui Diagnostics, LLC
- Product
- REF 822 IMUBIND(R) Plasma PAI-1 ELISA The intended use: Product is an enzyme-linked immunosorbent assay for the quantative measurement of human Plasminogen Activator Inhibitor Type-1 (PA-1) antigen in plasma.
- Product code
- GGP Test, Qualitative And Quantitative Factor Deficiency
- Reason for recall
- Unacceptable microwell to microwell variation in the section of the plate that is typically used for the calibrators
- Root cause tag
- manufacturing process
- FDA root cause
- Process control
- Action
- Three emails "REF 822 lot 102401 needs to be recalled" dated March 1, 2010 was sent to three customers. The emails described the product, problem and action to be taken by the customers. The customers should send the kit to the firm (SEKISUI american diagnostica inc.) attention of Leigh Ayres, Director, Regulatoy Affairs and Quality Assurance. If you have any question, please call 1-203-602-7777.
- Quantity in commerce
- 25 kits
- Distribution
- Worldwide distribution: USA and UK, Taiwan and Korea.
- Product codes and lots
- REF 822 lot 102401 CPT Code 85400 expires on 2010NOV24
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
